Yellow fever SDV 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTNN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,886
Award facts
- Contract value 100% obligated
- $18,886.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $18,886.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for Yellow Fever SDV 5S products. This firm fixed-price delivery order, awarded on February 4, 2026, with an ultimate completion date of February 13, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The order will be performed in Park Ridge, Illinois, and is funded by the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. The contract structure with its 30-month base period and three 30-month option periods positions DMS Pharmaceutical Group as a critical pharmaceutical supplier within the federal military medical supply chain, serving diverse therapeutic requirements across the global DoD healthcare system.
Quick answers
Who was awarded contract SPE2DR26FBTNN?
SPE2DR26FBTNN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FBTNN worth?
The government has obligated $18,886 on SPE2DR26FBTNN.
Is contract SPE2DR26FBTNN an order under another contract?
Yes. SPE2DR26FBTNN is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTNN competed?
The extent of competition for SPE2DR26FBTNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award